EXPERIMENTAL TREATMENT. WGAL NEWS 8’S SUSAN SHAPIRO EXPLAINS. SUSAN: PENN STATE HERSHEY MEDICAL CENTER IS WAITING FOR SHIPMENTS OF PLASMA FROM A NATIONAL REPOSITORY THAT WILL BE GIVEN TO 2 COVID-19 CLIENTS HOSPITALIZED HERE. IT WAS DONATED BY OTHER PATIENTS WHO EVALUATED POSITIVE AND HAVE SINCE RECOVERED.>> IS AN OLD TREATMENT. OLDIE BUT GOODIE. SUSAN: DR. EDWARD GUNTHER, A PROFESSOR OF MEDICINE, IS HEADING UP THE PROGRAM. DURING A ZOOM CONFERENCE TODAY HE STATED CONVALESCENT PLASMA HAS BEEN USED FOR DECADES TO TREAT INFECTIONS SUCCESSFULLY.>> ANTIBODIES THAT BATTLE INFECTION LIVE IN THE PLASMA AND IF SOMEBODY IS RECUPERATED FROM INFECTION, PLASMA FROM THT PERSON CAN BE TRANSFERRED TO A BLOOD-MATCHED RECIPIENT AND CAN BATTLE INFECTION FOR THE RECIPIENT CLIENT. SUSAN DR. GUNTHER SAID EARLY: DATA REVEALS THE TREATMENT IS SAFE, BUT THEY DON’T YET ABOUT WHETHER IT IS RESULT.
2 Penn State Hershey Medical Center COVID-19 clients will be given plasma as possible treatment
WGAL News 8 coronavirus updates
Penn State Health prepares to give COVID-19 patients an experimental treatment.Penn State Hershey Medical Center is waiting for the delivery of convalescent plasma from a national repository that will be offered to 2 clients. The plasma was contributed by other clients who tested favorable and have considering that recuperated from the coronavirus. “It’s an old treatment, however it’s an oldie however goodie,” stated Dr. Edward Gunther, a teacher at Penn State College of Medicine.Gunther is heading up the program. He said convalescent plasma has been used for years to effectively deal with infections.” The antibodies that battle infection live in the plasma, and if someone is recovered from infection, plasma from that individual can be transferred to a blood-matched recipient and can combat the infection for the recipient client,” Gunther said.Gunther said early information reveals the treatment is safe.It’s not clear yet whether the treatment is effective, but there’s a good chance it might help, Gunther said.The hospital is keeping an eye on recuperated coronavirus clients who might be able to contribute plasma. The hope is to establish a regional inventory that would be readily offered.
HERSHEY, Pa.–
Penn State Health plans to provide COVID-19 patients a speculative treatment.
Penn State Hershey Medical Center is awaiting the delivery of convalescent plasma from a nationwide repository that will be offered to 2 patients. The plasma was contributed by other patients who tested favorable and have because recuperated from the coronavirus.
” It’s an old treatment, but it’s an oldie but gift,” said Dr. Edward Gunther, a teacher at Penn State College of Medication.
Gunther is heading up the program. He said convalescent plasma has been used for decades to effectively deal with infections.
” The antibodies that combat infection reside in the plasma, and if somebody is recovered from infection, plasma from that person can be moved to a blood-matched recipient and can combat the infection for the recipient client,” Gunther said.
Gunther said early information shows the treatment is safe.
It’s not clear yet whether the treatment is effective, however there’s a good chance it might help, Gunther said.
The healthcare facility is monitoring recovered coronavirus patients who might have the ability to contribute plasma. The hope is to establish a regional stock that would be easily offered.
